Background
Methods
Literature Search and article inclusion
1. | choice behav*/ |
2. | decision making/ |
3. | shared decision making/ |
4. | information seeking behav*/ |
5. | help seeking behav* |
6. | or/1–5 |
7. | ((decision) adj (support* or aid or tool or instrument or technolog* or technique* or system* or program* or algorithm* or process* or method* or intervention* or material* or board* or guide* or counselling*)).tw. |
8. | ((decision support) adj (system* clinical or technolog*)).tw. |
9. | education technology/ |
10. | communication package/ |
11. | decision tree*/ |
12 | ((risk) adj (communication or assessment)).tw. |
13. | ((risk information) adj (tool or method)).tw. |
14 | ((interactive) adj (health communication or booklet or graphic or tool)).tw. |
15. | ((informed) adj (choice or decision)).tw. |
16. | or/7–15 |
17. | clinical trial/ |
18. | ((randomized or randomised) adj (controlled trial)).tw. |
19. | controlled clinical trial/ |
20. | randomized/ |
21. | randomised/ |
22. | placebo/ |
23. | random/ |
24. | trial/ |
25. | double blind method/ |
26. | or/17–25 |
27. | 6 and 16 and 26 |
Inclusion Criteria |
• Studies investigating treatment choices for an established health condition |
• Studies (randomised controlled trial design) comparing DAs to usual care, no intervention, alternative interventions |
• Studies for which the decision aids being investigated were available to the research team for subsequent content examination |
• Studies for which there was availability of associated documentation detailing development process of the decision aid |
• Articles published in English language |
Exclusion criteria |
• Studies including hypothetical choices |
• Decisions aids regarding: |
○ clinical trial entry |
○ screening/assessment |
○ advance health care directives (e.g. resuscitation status) |
○ educational programmes not directed toward decision making |
○ promoting adherence only |
○ eliciting informed consent only |
• Decisions made by a surrogate or guardian for a patient |
• Decision aids developed before 2006 |
Data extraction and analysis
Bias
Quality of Decision aids
Evidence used in DAs
Results
Results of search
Study characteristics
General characteristics | Control arm | Intervention arm | Results | |||||
---|---|---|---|---|---|---|---|---|
Publication | Context | Setting | Study design | Total no. of participants | Mean age | Control intervention | DA intervention | Main findings |
Arterburn 2011 [21] | People considering bariatric surgery | Group Health Cooperative in USA | Prospective, randomised controlled trial | 101 | 50.5 | Booklet with general information on severe obesity and surgical weight loss treatments | Video and booklet about bariatric surgery + guidance (list of questions to ask clinician) | Both groups improved significantly in knowledge (P < 0.001), values concordance (P = 0.009), decisional conflict (P < 0.001) and decisional self-efficacy (P < 0.001). DA group had larger improvements than control group in knowledge (P = 0.03), decision conflict (P = 0.03), and outcome expectancies (P = 0.001). No difference in proportion of participants choosing bariatric surgery between groups. |
Branda 2013 [22] | People with type 2 diabetes considering changing their antihyperglycaemic drugs or lipid lowering strategies | Rural primary care practices in USA | Cluster randomised controlled trial | 103 | 57.6 | Lipid therapy medication discussion OR Anti hyperglycaemic medication discussion | Diabetes Medication DA: decision cards with treatment information and usual care for lipid therapy OR Statin PtDA: 1-page DA with cardiovascular risk with and without medication, treatment information | DA group were more likely to report discussing medications (p < 0.001), answer knowledge questions correctly (risk reduction with statins, p = 0.07; knowledge about options p = 0.002) and were more engaged by their clinician in decision making (p = .01). No difference in patient satisfaction, decisional conflict, medication starts, adherence or clinical outcome |
Jibaja-Weiss 2011 [23] | Women diagnosed with breast cancer considering surgical treatment | Two breast pathology clinics in USA | Randomised controlled trial | 100 | 51 | Breast cancer educational materials | Computer based information, values clarification and guidance (step by step process for making the decision) | DA group more likely to choose mastectomy (P = 0.018). No difference in satisfaction between groups. Decreased decisional conflict for both groups (P < 0.001) across assessment periods but DA group more informed about options (P = 0.007) and clearer about values (trend at P = 0.053) at pre-surgery assessment. |
LeBlanc 2015 [24] | Women with osteopenia or osteoporosis | Primary care practices in USA | Randomised controlled trial | 77 | 67.5 | Clinicians discussed risk of fractures and treatment as usual without any research-related intervention OR clinicians were provided with patients’ individualised 10-year risk of bone fracture for use during the clinical encounter | 1-page decision aid with personalised risk of having a fracture with and without medication and information about harms and side effects | DA group had better knowledge (P = 0.01), improved understanding of fracture risk and risk reduction with medication (P = 0.01 and P < 0.0001, respectively), increased patient involvement (P = 0.001) but had no effect on decisional conflict. Consultations using DA were 0.8 min longer. DA arm had more patients receiving and filling prescriptions (P = 0.07), medication adherence was no different across arms at 6 months. |
LeBlanc 2015 [25] | People with moderate or severe depression | Primary care practices in USA | Cluster randomised trial | 297 | 43.5 | No access to decision aid | Seven laminated cards with information about treatments | DA significantly improved patients’ decision comfort (P = 0.02), knowledge (P = 0.03), satisfaction (P = 0.81 to P = 0.002, depending on domain) and involvement (P < 0.001) and clinicians’ decisional comfort (P < 0.001) and satisfaction (P = 0.02). No differences in consultation duration, adherence or improvement in depression control between groups. |
Mann 2010 [26] | People diagnosed with diabetes considering statins to reduce cardiovascular risk | Primary care practices in USA | Cluster randomised trial | 150 | 58 | Pamphlet about reducing cholesterol through diet | 1-page DA with cardiovascular risk with and without medication and information about statins | DA group more likely to accurately estimate risk of cardiac arrest without statin (OR: 1.9, CI: 1.0–3.8) and with statin (OR: 1.4, CI: 0.7–2.8). DA group reported stronger belief in the need for statins (OR 1.45, CI: 0.89–2.36) and were less likely to have concerns about long-term effects (OR: 0.44, CI: 0.20–0.97). DA resulted in improvements in decisional conflict (P = 0.1). No difference in statin adherence or knowledge between groups. |
Mathers 2012 [27] | People with type 2 diabetes considering insulin therapy | General practices in UK | Cluster randomised controlled trial | 175 | 64 | No access to decision aid | Booklet containing information on treatment options, values clarification + guidance | DA group had lower total Decisional Conflict Scores (p < 0.001); greater knowledge (p < 0.001); realistic expectations (p < 0.001); and more autonomy in decision making (p = 0.012). No significant difference in the glycaemic control between groups. |
Montori 2011 [28] | Postmenopausal women at risk of osteoporotic fractures | General medicine and primary care practises in USA | Multicentre, randomised controlled trial. | 100 | 67 | Review of bone mineral density results without fracture risk calculation or graphic representation of treatment benefit + general information booklet | 1-page decision aid with personalised risk of having a fracture with and without medication and information about harms and side effects | DA group were 1.8 times more likely to correctly identify fracture risk, 2.7 times more likely to identify risk reduction with bisphosphonates and demonstrated improved involvement in decision making process by 23%. Bisphosphonates started more in DA group, adherence similarly high at 6 months, across both groups but proportion with more than 80% adherence was higher in DA group. |
Mott 2014 [29] | War veterans with PTSD | PTSD clinic in USA | Randomised controlled trial | 27 | 29.3 | No access to decision aid | Booklet describing treatment options | Greater number of people in DA group preferred an evidence-based treatment and received an adequate dose of therapy compared to control (≥9 sessions). No difference in initiation rates of psychotherapy between groups. |
Mullan 2009 [30] | People with type 2 diabetes considering treatment options | Primary care and family medicine sites in USA | Cluster randomised trial | 85 | 62.1 | 12-page pamphlet on oral antihyperglycaemic medications | Six decision cards with information about treatments | DA group had better knowledge and more involvement in decision making. Similar scores for trust in physician and decisional conflict between groups. At follow-up, both groups had almost perfect medication use but there was no significant impact on HbA1c levels. |
Solberg 2010 [31] | Women considering treatment options for uterine fibroids | Gynaecology clinics in USA | Randomised controlled trial | 300 | 46 | Pamphlet about uterine fibroids | DVD and booklet, decision worksheet and nurse coach access | DA group reported more options being mentioned, had better knowledge scores, were more likely to report being adequately informed and decisions were both more satisfactory and consistent with personal values. |
Vandemheen 2009 [32] | People with cystic fibrosis considering lung transplantation | Outpatient centres in Canada and Australia | Single-blind, randomised controlled trial | 149 | 30.4 | Blank pages and a letter explaining why blank pages were included | Booklet with treatment information | DA group had better knowledge about options (P < 0.0001) and more realistic expectations (P < 0.0001). Decisional conflict was significantly lower in DA (P = 0.0007). |
Weymiller 2007 [33] | People with type 2 diabetes | Metabolic clinic in USA | Cluster randomised trial | 97 | 65 | Standard educational pamphlet on cholesterol management | 1-page DA with cardiovascular risk with and without medication and information about statins | DA group had better knowledge, estimated cardiovascular risk and potential absolute risk reduction with statin drugs, and had less decisional conflict. DA missed less doses than control group at 3-month follow-up. |
Cochrane Risk of Bias
Criteria | Sequence generation | Allocation concealment | Blinding (participants, personnel and outcome assessors) | Incomplete outcome data | Selective outcome reporting | Other sources of bias |
---|---|---|---|---|---|---|
Arterburn 2011 [24] | + | ? | ? | ? | ? | + |
Branda 2013 [25] | ? | ? | ? | ? | + | ? |
Jibaja-Weiss 2011 [26] | + | ? | ? | ? | ? | + |
LeBlanc 2015 [27] | + | ? | ? | + | + | + |
LeBlanc 2015 [28] | ? | ? | - | + | + | ? |
Mann 2010 [29] | ? | ? | ? | + | ? | ? |
Mathers 2012 [30] | ? | + | ? | + | + | ? |
Montori 2011 [31] | + | + | ? | + | + | + |
Mott 2014 [32] | + | ? | ? | ? | ? | + |
Mullan 2009 [33] | + | + | ? | ? | + | + |
Solberg 2010 [34] | ? | ? | ? | + | ? | + |
Vandemheen 2009 [35] | + | + | ? | + | + | + |
Weymiller 2007 [36] | + | ? | + | + | + | + |
Decision Aid Quality (IPDASi-SF)
Publication | Arterburn 2011 [21] | Jibaja-Weiss 2011 [23] | LeBlanc 2015 [24] | Mathers 2012 [27] | Mott 2014 [28] | Solberg 2010 [31] | Vandemheen 2009 [32] | |||
---|---|---|---|---|---|---|---|---|---|---|
Production Year | 2014 (update) | 2006 | 2007 | 2012 | 2008 | - | - | 2014 (update) | 2006 | 2007 |
Information | ||||||||||
Options available | + | + | + | + | + | + | + | + | + | + |
Positive features | + | + | + | + | + | + | + | + | + | + |
Negative features | + | + | + | + | + | + | + | + | + | + |
Fair comparison | + | + | + | + | + | + | + | + | + | + |
Probabilities | ||||||||||
Reference class | + | - | + | + | + | + | + | + | + | + |
Event rates | + | - | + | - | + | - | - | - | + | + |
Compare probabilities | + | - | + | + | + | + | - | + | - | + |
Values | ||||||||||
Personal importance | + | + | - | - | + | + | - | + | + | - |
Development | ||||||||||
Patients’ needs | + | + | + | + | + | - | + | + | + | + |
Impartial review | + | + | + | + | + | + | + | + | + | + |
Tested with patients | - | + | + | + | + | + | + | - | - | + |
Disclosure | ||||||||||
Information about funding | + | + | + | + | + | + | + | + | + | + |
DST evaluation | ||||||||||
Knowledge | + | + | + | + | + | - | + | + | + | + |
Improved decision quality | + | + | - | + | + | - | - | + | + | + |
Evidence | ||||||||||
Citations to studies | + | + | + | + | + | - | + | + | + | + |
Production date | + | + | + | + | + | - | - | + | + | + |
Total | 15 | 13 | 14 | 14 | 16 | 10 | 11 | 14 | 14 | 15 |
Evidence levels and sources in decision aids (novel framework)
Publications | Decision aid | Pillar of evidence | |||
---|---|---|---|---|---|
Research evidence | Practice evidence | Patient evidence | Contextual evidence | ||
Arterburn 2011 [24] | Weight Loss Surgery: Is it right for you? | A1 | B1 | A1 | B |
Jibaja-Weiss 2011 [26] | A Patchwork of Life: One Woman’s Story | A1 | D | B2 | B |
Osteoporosis Choice | A1 | C2 | D | B | |
LeBlanc 2015 [28] | Depression Medication Choice | A1 | D | D | B |
Mathers 2012 [30] | Starting Insulin. Your Choice. | A2 | D | D | B |
Mott 2014 [32] | Getting help for PTSD: A guide to finding the right treatment for you | D1 | D | D | B |
Diabetes Medication Choice | A1 | D | D | B | |
Solberg 2010 [34] | Treatment choices for uterine fibroids | A1 | B1 | A1 | B |
Vandemheen 2009 [35] | When your lung function is getting worse… Should you be referred for a lung transplant? A decision aid for adults with cystic fibrosis | D1 | D | D | A |
Statin Choice | A1 | D | D | B |